BACKGROUND: An 800-mcg dose of buccal misoprostol following mifepristone has been
shown to be highly effective in terminating pregnancies through 63 days since the last …

Objective To determine the efficacy of oral mifepristone followed by vaginal misoprostol 6
hours later compared with the standard 36‐to 48‐hour regimen for medical termination of …

Given the highly political nature of abortion in the United States, the provision of medical
abortion with mifepristone (Mifeprex®) and misoprostol has always occurred under a unique …

DESIGN: A retrospective analysis of 386 women who underwent termination of pregnancy
between 12 and 24 weeks' gestation. METHODS: Each woman received 200 mg …

BACKGROUND: A combination of mifepristone and misoprostol provides an effective
method of medical abortion for early pregnancy. A new route of administration of …

Objective To test the effectiveness and acceptability of an outpatient medical abortion
protocol with 200 mg mifepristone and 400 mcg sublingual misoprostol at 64–70 days' last …

Of the total women included in the study, 96 women chose to receive misoprostol 600 μg
sublingually while 53 women received misoprostol 800 μg vaginally 36–48 h after receiving …

BACKGROUND: The aim of the study was to assess efficacy and safety of administering 200
mg of mifepristone between 36 and 48 h before the insertion of 800 mcg of vaginal …

OBJECTIVE: The study was conducted to compare the efficacy of two different dose
regimens of misoprostol administered vaginally in combination with mifepristone for second …

Objective Abortion-related complications remain one of the leading causes of maternal
morbidity and mortality worldwide. Nearly half of all abortions are unsafe, and the vast …